Literature DB >> 2312537

Abnormal magnetic-resonance scans of the lumbar spine in asymptomatic subjects. A prospective investigation.

S D Boden1, D O Davis, T S Dina, N J Patronas, S W Wiesel.   

Abstract

We performed magnetic resonance imaging on sixty-seven individuals who had never had low-back pain, sciatica, or neurogenic claudication. The scans were interpreted independently by three neuro-radiologists who had no knowledge about the presence or absence of clinical symptoms in the subjects. About one-third of the subjects were found to have a substantial abnormality. Of those who were less than sixty years old, 20 per cent had a herniated nucleus pulposus and one had spinal stenosis. In the group that was sixty years old or older, the findings were abnormal on about 57 per cent of the scans: 36 per cent of the subjects had a herniated nucleus pulposus and 21 per cent had spinal stenosis. There was degeneration or bulging of a disc at at least one lumbar level in 35 per cent of the subjects between twenty and thirty-nine years old and in all but one of the sixty to eighty-year-old subjects. In view of these findings in asymptomatic subjects, we concluded that abnormalities on magnetic resonance images must be strictly correlated with age and any clinical signs and symptoms before operative treatment is contemplated.

Entities:  

Mesh:

Year:  1990        PMID: 2312537

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  410 in total

1.  Three pathways between the sacroiliac joint and neural structures.

Authors:  J D Fortin; W J Washington; F J Falco
Journal:  AJNR Am J Neuroradiol       Date:  1999-09       Impact factor: 3.825

Review 2.  Recurrent posterior thigh symptoms detrimental to performance in rugby union: predisposing factors.

Authors:  L Devlin
Journal:  Sports Med       Date:  2000-04       Impact factor: 11.136

Review 3.  Influence of age on the development of pathology.

Authors:  P S Sizer; O Matthijs; V Phelps
Journal:  Curr Rev Pain       Date:  2000

4.  Prospective Comparison of Changes in Lumbar Spine MRI Findings over Time between Individuals with Acute Low Back Pain and Controls: An Exploratory Study.

Authors:  J Panagopoulos; J S Magnussen; J Hush; C G Maher; M Crites-Battie; J G Jarvik; T S Jensen; M J Hancock
Journal:  AJNR Am J Neuroradiol       Date:  2017-08-03       Impact factor: 3.825

5.  Continuous quality improvement for patients with back pain.

Authors:  R A Deyo; M Schall; D M Berwick; T Nolan; P Carver
Journal:  J Gen Intern Med       Date:  2000-09       Impact factor: 5.128

6.  Lumbar root compression in the lateral recess: MR imaging, conventional myelography, and CT myelography comparison with surgical confirmation.

Authors:  Walter S Bartynski; Luke Lin
Journal:  AJNR Am J Neuroradiol       Date:  2003-03       Impact factor: 3.825

7.  The aging of the population: a growing concern for spine care in the twenty-first century.

Authors:  Marek Szpalski; Robert Gunzburg; Christian Mélot; Max Aebi
Journal:  Eur Spine J       Date:  2003-09-03       Impact factor: 3.134

8.  Transforaminal epidural Etanercept for the treatment of prolapsed lumbar intervertebral disc induced sciatica.

Authors:  Ashish Dagar; Ramesh Kumar; Abhishek Kashyap; Vinay Prabhat; Hitesh Lal; Lalit Kumar
Journal:  J Clin Orthop Trauma       Date:  2016-10-25

9.  The reliability of differentiating neurogenic claudication from vascular claudication based on symptomatic presentation.

Authors:  Mélissa Nadeau; M Patricia Rosas-Arellano; Kevin R Gurr; Stewart I Bailey; David C Taylor; Ruby Grewal; D Kirk Lawlor; Chris S Bailey
Journal:  Can J Surg       Date:  2013-12       Impact factor: 2.089

10.  Great trochanter bursitis vs sciatica, a diagnostic-anatomic trap: differential diagnosis and brief review of the literature.

Authors:  Aristeidis H Zibis; Vasileios D Mitrousias; Michail E Klontzas; Theofilos Karachalios; Sokratis E Varitimidis; Apostolos H Karantanas; Dimitrios L Arvanitis
Journal:  Eur Spine J       Date:  2018-02-01       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.